what brand is tirzepatide Lilly's Weight-Loss Drug Approved in China Amid Race With Novo How the weight loss drug

The SELECT trial results established GLP-1 receptor activation as cardioprotective in ways that previous surrogate marker improvements only suggested

A systematic review of the quality of life for families supporting a child consuming the ketogenic diet for seizure reduction

In December 2024, Zepbound received an additional indication for treating adults with OSA and obesity and is the first pharmaceutical treatment for OSA

During sleep, the body undergoes repair processes, including those related to hair growth and pigmentation

The Hathaway study reported higher hazard ratios for NAION in patients with obesity (7.64) compared to those with type 2 diabetes (4.28)

: : 04 1397 04 1397 32K - (L-3 hydroxytrimethylaminobutanoate) Carnus ( )